EU Pharma Reform: Negotiations Could See Patient Voice ‘Discarded,’ Warn Patient Groups

 
• By Eliza Slawther

An enhanced role for patients in the European Medicines Agency was a key proposal within the EU pharmaceutical legislation overhaul – but patient groups warn this provision could be scrapped or weakened due to ongoing negotiations.

Plans to include patients in EMA committees could be scrapped under the new pharma legislation reform, patient groups say (Shutterstock)

More from EU Pharma Legislation Reform

More from Pathways & Standards